|This article is orphaned as few or no other articles link to it.
Please help introduce links in articles on related topics.
|SMILES||CN1C=NC=C1C(C2=CC=C(C=C2)Cl) (C3=CC4=C(C=C3)N(C(=O) C=C4C5=CC(=CC=C5)Cl)C)N|
|Except where noted otherwise, data are given for|
materials in their standard state
(at 25 °C, 100 kPa)
Infobox disclaimer and references
Tipifarnib (Zarnestra) is a drug that is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML).
The compound was discovered by and is under investigation by Johnson & Johnson Pharmaceutical Research & Development, L.L.C, with registration number R115777.